AUTHOR=Taylor Kenneth A. , Carroll Megan K. , Short Sarah A. , Celestin Bettia E. , Gilbertson Adam , Olivier Christoph B. , Haddad Francois , Cauwenberghs Nicholas TITLE=Factors associated with lower quarter performance-based balance and strength tests: a cross-sectional analysis from the project baseline health study JOURNAL=Frontiers in Sports and Active Living VOLUME=6 YEAR=2024 URL=https://www.frontiersin.org/journals/sports-and-active-living/articles/10.3389/fspor.2024.1393332 DOI=10.3389/fspor.2024.1393332 ISSN=2624-9367 ABSTRACT=Objectives

Physical performance tests are predictive of mortality and may screen for certain health conditions (e.g., sarcopenia); however, their diagnostic and/or prognostic value has primarily been studied in age-limited or disease-specific cohorts. Our objective was to identify the most salient characteristics associated with three lower quarter balance and strength tests in a cohort of community-dwelling adults.

Methods

We applied a stacked elastic net approach on detailed data on sociodemographic, health and health-related behaviors, and biomarker data from the first visit of the Project Baseline Health Study (N = 2,502) to determine which variables were most associated with three physical performance measures: single-legged balance test (SLBT), sitting-rising test (SRT), and 30-second chair-stand test (30CST). Analyses were stratified by age (<65 and ≥65).

Results

Female sex, Black or African American race, lower educational attainment, and health conditions such as non-alcoholic fatty liver disease and cardiovascular conditions (e.g., hypertension) were consistently associated with worse performance across all three tests. Several other health conditions were associated with either better or worse test performance, depending on age group and test. C-reactive protein was the only laboratory value associated with performance across age and test groups with some consistency.

Conclusions

Our results highlighted previously identified and several novel salient factors associated with performance on the SLBT, SRT, and 30CST. These tests could represent affordable, noninvasive biomarkers of prevalent and/or future disease in adult individuals; future research should validate these findings.

Clinical Trial Registration

ClinicalTrials.gov, identifier NCT03154346, registered on May 15, 2017.